These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17633023)

  • 1. TRAF proteins in CD40 signaling.
    Bishop GA; Moore CR; Xie P; Stunz LL; Kraus ZJ
    Adv Exp Med Biol; 2007; 597():131-51. PubMed ID: 17633023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outside inside signalling in CD40-mediated B cell activation.
    D'Orlando O; Gri G; Cattaruzzi G; Merluzzi S; Betto E; Gattei V; Pucillo C
    J Biol Regul Homeost Agents; 2007; 21(3-4):49-62. PubMed ID: 18261257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
    Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
    Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF-dependent association of protein kinase Tpl2/COT1 (MAP3K8) with CD40.
    Chan H; Reed JC
    Biochem Biophys Res Commun; 2005 Mar; 328(1):198-205. PubMed ID: 15670770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
    Aicher A; Shu GL; Magaletti D; Mulvania T; Pezzutto A; Craxton A; Clark EA
    J Immunol; 1999 Dec; 163(11):5786-95. PubMed ID: 10570261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death.
    Kehry MR
    J Immunol; 1996 Apr; 156(7):2345-8. PubMed ID: 8786287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
    Hostager BS; Bishop GA
    J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40/CD40L signaling and its implication in health and disease.
    Chatzigeorgiou A; Lyberi M; Chatzilymperis G; Nezos A; Kamper E
    Biofactors; 2009; 35(6):474-83. PubMed ID: 19904719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The essential region of CD40 cytoplasmic domain for signal transduction in WEHI231 cells].
    Hara T
    Hokkaido Igaku Zasshi; 1997 May; 72(3):309-17. PubMed ID: 9226470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of an altered CD40 signaling complex by an antagonistic human monoclonal antibody to CD40.
    Bankert KC; Oxley KL; Smith SM; Graham JP; de Boer M; Thewissen M; Simons PJ; Bishop GA
    J Immunol; 2015 May; 194(9):4319-27. PubMed ID: 25795759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.
    Xie P; Hostager BS; Bishop GA
    J Exp Med; 2004 Mar; 199(5):661-71. PubMed ID: 14981114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
    Li X
    Cytokine; 2008 Feb; 41(2):105-13. PubMed ID: 18061473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF-mediated TNFR-family signaling.
    Ha H; Han D; Choi Y
    Curr Protoc Immunol; 2009 Nov; Chapter 11():11.9D.1-11.9D.19. PubMed ID: 19918944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y; Hostager BS; Bishop GA
    J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
    Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
    Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation.
    Georgopoulos NT; Steele LP; Thomson MJ; Selby PJ; Southgate J; Trejdosiewicz LK
    Cell Death Differ; 2006 Oct; 13(10):1789-801. PubMed ID: 16429118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.